ORC
IBB icon

O'Rourke & Company’s iShares Biotechnology ETF IBB Stock Holding History

O'Rourke & Company’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Sell
6,521
-132
-2% -$22.6K 0.44% 58
2025
Q4 		$1.12M Buy
6,653
+357
+6% +$58K 0.44% 55
2025
Q3 		$909K Sell
6,296
-213
-3% -$29.1K 0.38% 63
2025
Q2 		$823K Sell
6,509
-216
-3% -$26.5K 0.38% 64
2025
Q1 		$860K Buy
6,725
+2
+0% +$271 0.43% 55
2024
Q4 		$889K Sell
6,723
-136
-2% -$19.1K 0.44% 52
2024
Q3 		$999K Buy
6,859
+234
+4% +$33.9K 0.5% 44
2024
Q2 		$909K Hold
6,625
– – 0.51% 43
2024
Q1 		$909K Sell
6,625
-142
-2% -$19.4K 0.53% 42
2023
Q4 		$919K Buy
6,767
+200
+3% +$24.4K 0.59% 40
2023
Q3 		$803K Sell
6,567
-114
-2% -$14.5K 0.59% 41
2023
Q2 		$848K Sell
6,681
-150
-2% -$19.5K 0.59% 37
2023
Q1 		$882K Buy
6,831
+70
+1% +$9.16K 0.67% 36
2022
Q4 		$888K Buy
6,761
+2
+0% +$258 0.7% 36
2022
Q3 		$791K Sell
6,759
-197
-3% -$24.5K 0.69% 36
2022
Q2 		$818K Sell
6,956
-742
-10% -$88.1K 0.69% 38
2022
Q1 		$1M Sell
7,698
-1,004
-12% -$131K 0.69% 38
2021
Q4 		$1.33M Buy
+8,702
New +$1.35M 0.89% 25

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

O'Rourke & Company's IBB Position: Q1 2026 in Review

O'Rourke & Company reduced its iShares Biotechnology ETF (IBB) stake by 2% in Q1 2026, selling an estimated $22.6K and leaving 6,521 shares worth $1.1M. The position accounts for 0.44% of the portfolio, ranked #58.

O'Rourke & Company first reported a position in IBB in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.33M in Q4 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • O'Rourke & Company held 6,521 shares of iShares Biotechnology ETF worth $1.1M as of Q1 2026.
  • O'Rourke & Company sold 132 iShares Biotechnology ETF shares in Q1 2026, an estimated $22.6K.
  • iShares Biotechnology ETF made up 0.44% of O'Rourke & Company's portfolio in Q1 2026, its #58 holding.
  • O'Rourke & Company first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 18 quarters since.
  • O'Rourke & Company's iShares Biotechnology ETF position peaked at $1.33M in Q4 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on O'Rourke & Company's 13F filing for Q1 2026, filed 14 May 2026.